Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders

[1]  J. Kira,et al.  Anti-neurofascin antibody in patients with combined central and peripheral demyelination , 2013, Neurology.

[2]  K. Kleopa,et al.  Alterations of juxtaparanodal domains in two rodent models of CNS demyelination , 2013, Glia.

[3]  J. Kira,et al.  Anti‐KIR4.1 antibodies in Japanese patients with idiopathic central nervous system demyelinating diseases , 2013 .

[4]  D. Bourdette,et al.  Autoantibodies and Sjogren’s Syndrome in Multiple Sclerosis, a Reappraisal , 2013, PloS one.

[5]  P. Mattis,et al.  Cognitive and Emotional Abnormalities in Systemic Lupus Erythematosus: Evidence for Amygdala Dysfunction , 2012, Neuropsychology Review.

[6]  Bernhard Hemmer,et al.  Potassium channel KIR4.1 as an immune target in multiple sclerosis. , 2012, The New England journal of medicine.

[7]  P. Villoslada,et al.  Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis , 2012, Journal of Neuroimmunology.

[8]  Esther B. E. Becker,et al.  Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  A. Vincent,et al.  Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis/New serological markers for the differential diagnosis of autoimmune limbic encephalitis , 2011 .

[10]  K. Strauss,et al.  Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia , 2011, Annals of neurology.

[11]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[12]  M. Kinoshita,et al.  [Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy]. , 2010, Rinsho shinkeigaku = Clinical neurology.

[13]  E. Waubant,et al.  NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA , 2010, Neurology.

[14]  I. Izbudak,et al.  Distinct subtypes of myelitis in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[15]  H. Baba,et al.  Neurological Improvement Associated with Resolution of Irradiation‐Induced Myelopathy: Serial Magnetic Resonance Imaging and Positron Emission Tomography Findings , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[16]  H. Lassmann,et al.  Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals , 2009, Proceedings of the National Academy of Sciences.

[17]  R. Balice-Gordon,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[18]  T. Yuasa,et al.  A case of anti-aquaporin-4 and anti-glutamate receptor antibodies positive myelitis presented with modest clinical signs. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[19]  D. Arnold,et al.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. , 2008, The New England journal of medicine.

[20]  Y. Takahashi,et al.  Detection of Autoantibodies against NMDA-Type Glutamate Receptor in a Patient with Recurrent Optic Neuritis and Transient Cerebral Lesions , 2007, Neuropediatrics.

[21]  T. Olsson,et al.  Neurofascin as a novel target for autoantibody-mediated axonal injury , 2007, The Journal of experimental medicine.

[22]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[23]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[24]  Y. Itoyama,et al.  Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. , 2007, Brain : a journal of neurology.

[25]  J. Girault,et al.  Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. , 2006, Brain : a journal of neurology.

[26]  M. Krumbholz,et al.  B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation , 2006, Annals of neurology.

[27]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[28]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[29]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[30]  B. Weinshenker,et al.  Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange , 2005, The Lancet.

[31]  F. Aloisi,et al.  Unveiling the enigma of the CNS as a B-cell fostering environment. , 2005, Trends in immunology.

[32]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[33]  A. Tzioufas,et al.  The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[34]  Colin L. Stewart,et al.  Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1 , 2003, The Journal of cell biology.

[35]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[36]  Peter Shrager,et al.  Caspr2, a New Member of the Neurexin Superfamily, Is Localized at the Juxtaparanodes of Myelinated Axons and Associates with K+ Channels , 1999, Neuron.

[37]  Y. Itoyama,et al.  Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies , 1998, Journal of the Neurological Sciences.

[38]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[39]  G. Sandini,et al.  Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. , 2009, Brain : a journal of neurology.

[40]  L. Lenz,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .